Evidence map›Paper›PMID 29474504›Full record

ArticlePloS one2018

The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood.

Ales Tichy, Sylwia Kabacik, Grainne O'Brien, Jaroslav Pejchal, Zuzana Sinkorova, Adela Kmochova, Igor Sirak, Andrea Malkova, Caterina Gomila Beltran, Juan Ramon Gonzalez and 12 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
  9. Dose Variations Using an X-Ray Cabinet to EstablishFrontiers in public health · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ales TichyDepartment of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.ORCID 0000-0002-8262-5703
Sylwia KabacikCancer Mechanisms and Biomarkers group, Radiation Effects Department, Centre for Radiation, Chemical and Environmental Hazards, Public Health of England, Didcot, United Kingdom.
Grainne O'BrienCancer Mechanisms and Biomarkers group, Radiation Effects Department, Centre for Radiation, Chemical and Environmental Hazards, Public Health of England, Didcot, United Kingdom.
Jaroslav PejchalDepartment of Toxicology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Czech Republic.
Zuzana SinkorovaDepartment of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Adela KmochovaDepartment of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Igor SirakDepartment of Oncology and Radiotherapy and 4th Department of Internal Medicine - Hematology, University Hospital, Hradec Králové, Czech Republic.
Andrea MalkovaDepartment of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
Caterina Gomila BeltranInstitute for Global Health, Barcelona, Spain.
Juan Ramon GonzalezInstitute for Global Health, Barcelona, Spain.
Jakub GreplDepartment of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Matthaeus MajewskiBundeswehr Institute of Radiobiology, Munich, Germany.
Elizabeth AinsburyCancer Mechanisms and Biomarkers group, Radiation Effects Department, Centre for Radiation, Chemical and Environmental Hazards, Public Health of England, Didcot, United Kingdom.
Lenka ZarybnickaDepartment of Radiobiology, Faculty of Military Health Sciences, Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Jana VachelovaDepartment of Radiation Dosimetry, Nuclear Physics Institute of the Czech Academy of Sciences, Prague, Czech Republic.
Alzbeta ZavrelovaDepartment of Oncology and Radiotherapy and 4th Department of Internal Medicine - Hematology, University Hospital, Hradec Králové, Czech Republic.
Marie DavidkovaDepartment of Radiation Dosimetry, Nuclear Physics Institute of the Czech Academy of Sciences, Prague, Czech Republic.
Marketa Markova StastnaInstitute for Hematology and Blood Transfusion, Hospital Na Bulovce, Prague, Czech Republic.
Michael AbendBundeswehr Institute of Radiobiology, Munich, Germany.
Eileen PernotInstitute for Global Health, Barcelona, Spain.
Elisabeth CardisInstitute for Global Health, Barcelona, Spain.
Christophe BadieCancer Mechanisms and Biomarkers group, Radiation Effects Department, Centre for Radiation, Chemical and Environmental Hazards, Public Health of England, Didcot, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing risk of acute large-scale radiological/nuclear exposures of population underlines the necessity of developing new, rapid and high throughput biodosimetric tools for estimation of received dose and initial triage. We aimed to compare the induction and persistence of different radiation exposure biomarkers in human peripheral blood in vivo. Blood samples of patients with indicated radiotherapy (RT) undergoing partial body irradiation (PBI) were obtained soon before the first treatment and then after 24 h, 48 h, and 5 weeks; i.e. after 1, 2, and 25 fractionated RT procedures. We collected circulating peripheral blood from ten patients with tumor of endometrium (1.8 Gy per fraction) and eight patients with tumor of head and neck (2.0-2.121 Gy per fraction). Incidence of dicentrics and micronuclei was monitored as well as determination of apoptosis and the transcription level of selected radiation-responsive genes. Since mitochondrial DNA (mtDNA) has been reported to be a potential indicator of radiation damage in vitro, we also assessed mtDNA content and deletions by novel multiplex quantitative PCR. Cytogenetic data confirmed linear dose-dependent increase in dicentrics (p < 0.01) and micronuclei (p < 0.001) in peripheral blood mononuclear cells after PBI. Significant up-regulations of five previously identified transcriptional biomarkers of radiation exposure (PHPT1, CCNG1, CDKN1A, GADD45, and SESN1) were also found (p < 0.01). No statistical change in mtDNA deletion levels was detected; however, our data indicate that the total mtDNA content decreased with increasing number of RT fractions. Interestingly, the number of micronuclei appears to correlate with late radiation toxicity (r2 = 0.9025) in endometrial patients suggesting the possibility of predicting the severity of RT-related toxicity by monitoring this parameter. Overall, these data represent, to our best knowledge, the first study providing a multiparametric comparison of radiation biomarkers in human blood in vivo, which have potential for improving biological dosimetry.

Indexed as

Radiation ExposureAgedAged, 80 and overBiomarkersChromosome AberrationsDNA, MitochondrialDose-Response Relationship, RadiationEndometrial NeoplasmsFemaleHead and Neck NeoplasmsHumansLeukocytesMaleMicronuclei, Chromosome-DefectiveMiddle AgedRadiometryBiomarkersDNA, Mitochondrial

Identifiers

PMID29474504
PMCPMC5825084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.